Latest Documents


  • 4-May-2018

    English

    Memorandum of Understanding between the OECD and the Guangdong Provincial Centre for Disease Control and Prevention

    The OECD welcomed a Memorandum of Understanding (MOU) between the Guangdong Provincial Centre for Disease Control and Prevention and the OECD which will support China’s efforts in chemicals regulation and policy making.

    Related Documents
  • 20-April-2018

    English

    Good Laboratory Practice (GLP)

    This new Advisory Document provides clarity for test facilities on the expectations of national Good Laboratory Practice (GLP) compliance monitoring authorities regarding how test items are transported, received, identified, labelled, sampled, handled, stored, characterised, archived and disposed according to the Principles of OECD GLP.

    Related Documents
  • 9-April-2018

    English

    Intellectual Property elements in OECD Test Guidelines

    Ten years ago, OECD started to develop tools to avoid market monopoly as far as possible, to avoid abusive situations and to maintain transparency in OECD Test Guidelines containing Intellectual Property (IP) elements. Find out how the OECD address protected elements in OECD Test Guidelines.

    Related Documents
  • 21-March-2018

    English

    Series on Testing and Assessment: Testing for Endocrine Disrupters

    The series on endocrine disrupters provides common tools and guidances for testing the effects of endocrine disrupting chemicals on the oestrogen, androgen and thyroid hormone systems. Using these validated methodologies, regulatory authorities can use internationally harmonised tools to evaluate chemicals of concern for human health and the environment.

    Related Documents
  • 20-March-2018

    English

    OECD Work Related to Endocrine Disrupters

    The 2018 update of the OECD endocrine disrupting chemicals brochure is now available. The brochure explains why and how OECD became a key player on the issue of endocrine disrupters testing and assessment over the last two decades. It also provides background on endocrine disrupters, and outlines major achievements.

    Related Documents
  • 8-March-2018

    English

    Adverse Outcome Pathways, Molecular Screening and Toxicogenomics

    AOP-Wiki version 2.2 contains a large number of new features including multiple navigational tips, the redesign of the AOP pages, the update of the snapshot format to match the new AOP Users' handbook and a new format (AOP-XML) allowing the users to obtain all AOP-Wiki content in an easily usable form. AOP-Wiki users are encouraged to follow our new AOP Users' Handbook providing practical instructions on AOP development.

    Related Documents
  • 23-February-2018

    English

    OECD Good Laboratory Practice: Frequently asked questions (FAQ)

    GLP issues raised by testing labs are covered in this comprehensive list of questions and answers, recently updated with questions related to: sponsors, Contract Research Organisations (CROs), sub-contractors, archives, Information Technology (IT), Biotechnology/GMOs and other miscellaneous issues

    Related Documents
  • 28-January-2018

    English

    Draft Guidance and Review Documents/Monographs

    Deadlines for comments: Draft Guidance Document on Good In Vitro Method Practices (GIVIMP) for the Development and Implementation of In Vitro Methods for Regulatory Use in Human Safety Assessment by 28 February 2018.

    Related Documents
  • 10-January-2018

    English

    Series on Testing and Assessment: publications by number

    Latest report on the OECD Workshop on Intellectual Property Issues in OECD Test Guidelines (No. 278) inviting experts in intellectual property, regulatory standards, and innovative test methods for chemical safety testing to present and discuss issues associated with the availability, distribution means and transparent access to protected elements in OECD Test Guidelines (TGs).

    Related Documents
  • 10-January-2018

    English

    Section 4: Health Effects

    Deadlines for comments of OECD Guideline For The Testing Of Chemicals. Repeated Dose 90-Day Oral Toxicity Study in Rodents by 21 February.

    Related Documents
  • 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>